March 24, 2026
Gilgamesh Pharmaceuticals
Gilgamesh Pharmaceuticals is a clinical-stage biotechnology...
- Round
- Series A
- Amount raised
- $60M
- Lead investor
- National Institute on Drug
- Industry
- Biotechnology, Health Care
- Headquarters
- New York, New York
- Employees
- 11-50
- —